FDA Immediate Approval Of Pearson Health Claims Sought By Legislators
This article was originally published in The Tan Sheet
Executive Summary
FDA should "immediately" approve the four health claims that were the subject of the Pearson v. Shalala case, House Republicans Ron Paul (Tex.), Helen Chenoweth (Idaho), Merrill Cook (Utah), John Hostetler (Ind.) and Bob Stump (Ariz.) and Democrat Peter DeFazio (Ore.) state in a July 22 letter to the agency. FDA should "make all necessary changes to its rules, regulations and procedures to ensure compliance with the Pearson decision," they say.
You may also be interested in...
FDA Revised Strategy Toward Health Claims Requested By Pearson Plaintiffs
A revision of FDA's strategy for dealing with the four health claims the agency was ordered to reconsider under the Pearson v. Shalala decision is requested by plaintiffs' counsel Jonathan Emord (Washington, D.C.-based Emord & Associates) in a Sept. 23 letter to the agency. The letter asks FDA to notify the plaintiffs of such changes by Oct. 15.
FDA Revised Strategy Toward Health Claims Requested By Pearson Plaintiffs
A revision of FDA's strategy for dealing with the four health claims the agency was ordered to reconsider under the Pearson v. Shalala decision is requested by plaintiffs' counsel Jonathan Emord (Washington, D.C.-based Emord & Associates) in a Sept. 23 letter to the agency. The letter asks FDA to notify the plaintiffs of such changes by Oct. 15.
FDA Revised Strategy Toward Health Claims Requested By Pearson Plaintiffs
A revision of FDA's strategy for dealing with the four health claims the agency was ordered to reconsider under the Pearson v. Shalala decision is requested by plaintiffs' counsel Jonathan Emord (Washington, D.C.-based Emord & Associates) in a Sept. 23 letter to the agency. The letter asks FDA to notify the plaintiffs of such changes by Oct. 15.